Travere Therapeutics Inc (TVTX) is a biotechnology company listed on US.
Latest reported TVTX revenue for 2026-06-30 was $296.8M. Net income was -$71.9M. TVTX currently screens at market cap $1.33B.
Use this TVTX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the TVTX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the TVTX SEC filings page. Lician reads the product cache first so this HTML stays unique to Travere Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full TVTX income, balance, and cash tables.